Giovanni Leo

Partner Lake Geneva Ventures at Efficient Frontier Investing · Switzerland

Invests in AI

AI is one of the sectors on Giovanni Leo's investor profile, next to Healthcare & Biotech, MedTech & Medical Devices and Biotech & Pharma, at seed and early-stage venture. The record holds 6 deals, including Hylomorph, CV Lab and EBAMed.

Email Investor

Email Investor

Credits to line up before a seed round

Giovanni Leo backs companies at seed and early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Hylomorph
  • CV Lab
  • EBAMed
  • Acrostak Corp
  • Medyria
  • Terapet SA

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, MedTech & Medical Devices, Biotech & Pharma
Rounds
Seed, Early-stage venture
Profile
Angel investor
Deals on record
6
Based in
Switzerland

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Giovanni Leo invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Giovanni Leo's investor profile, together with Healthcare & Biotech, MedTech & Medical Devices and Biotech & Pharma. The stages on record are seed and early-stage venture.
Which companies has Giovanni Leo backed?
The record lists 6 deals, including Hylomorph, CV Lab, EBAMed, Acrostak Corp and Medyria. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Giovanni Leo?
For a company raising a seed round, AI Perks lists credits such as Appwrite (up to $20,000), Vertex AI (up to $350,000), GitLab (up to $12,000) and Vercel (up to $850,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor